Author

Berta Estrada-Bes

Institut de Recerca Sant Joan de Déu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Carla Ríos-AstorchiD· 1 shared Cinzia Emilia LavarinoiD· 1 shared Enrique BlancoiD· 1 shared Estela PradaiD· 1 shared Florencia Cidre‐AranaziD· 1 shared Jaume MoraiD· 1 shared Luciano Di CroceiD· 1 shared María Sánchez-JiméneziD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Carla Ríos-AstorchORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

USP7 sustains PAX3::FOXO1 enhancer reprogramming and represents a therapeutic vulnerability in Rhabdomyosarcoma

Pablo Táboas, Enrique Blanco, Estela Prada, Tobias Faehling, María Sánchez-Jiménez, Carla Ríos-Astorch, Merce Baulenas‐Farres, Berta Estrada-Bes, Xenia Cuadros-Hernández, Silvia Mateo‐Lozano, Soledad Gómez‐González, Sara Pérez‐Jaume, Cinzia Emilia Lavarino, Thomas G. P. Grünewald, Florencia Cidre‐Aranaz, , Sara Sánchez-Molina

This study identifies USP7 as a critical regulator of PAX3::FOXO1 enhancers in FP-RMS and shows its inhibition reduces tumor growth.

bioRxiv · Jun 8, 2026 · PreprintCancer Biology